English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 44607/57715 (77%)
造訪人次 : 1621401      線上人數 : 40
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/63451


    題名: 探究粒線體衍生?對粒線體功能障礙的細胞清除作用
    Investigating the Clearance Effects of Mitochondrial-Derived Peptides on Mitochondrial Dysfunction
    作者: 許舒媛
    Hsu, Shu-Yuan
    貢獻者: 醫學檢驗暨生物技術學系碩士班
    高淑慧
    關鍵詞: 粒線體;粒線體衍生?;粒線體功能障礙;人類素
    mitochondria;Mitochondrial-Derived Peptides;Mitochondrial Dysfunction;Humanin
    日期: 2023-01-11
    上傳時間: 2024-01-22 13:23:41 (UTC+8)
    摘要: 粒線體自噬作用是細胞損傷調控機制之一,其作用為去除失去功能及多餘的粒線體,以利控制粒線體的數量及能量代謝的平衡。在粒線體大片段缺失而導致突變的皮膚纖維母細胞中,相關之粒線體清除機制顯得尤為重要,透過清除突變型的粒線體,使體內相關基因之表達保持平衡,可以減緩過多的代償作用或基因缺失所導致的細胞能量生成缺陷。由先前研究發現,粒線體衍胜? (mitochondrial- derived pepetide, MDP)之一的人類素 (Humanin) 為細胞保護和能量生成的調節訊息分子,人類素可經由細胞內和細胞外活化路徑,有效調節粒線體至細胞核逆行訊息,以此來應對嚴重的粒線體損傷和細胞壓力。本研究的研究主旨在探究人類素可否有效調控粒線體的自噬作用,以期加快清除體內突變之粒線體,使患者不會因過多突變型的粒線體堆積而導致相關疾病。本研究透過體外培養含粒線體基因斷損突變患者-Pearson症患者的初代纖維母細胞 (patient fibroblasts, PF) 以及與健康對照組 (normal fibroblasts, NF) 或是Detriol559 (Det) 人類表皮纖維母細胞株為實驗細胞模式,進行了解人類素 (Humanin),對於粒線體突變型之皮膚纖維母細胞的影響。由先前的研究中發現,透過病患纖維母細胞與健康對照組之比較,人類素能有效降低因粒線體基因損害所導致的粒線體DNA拷貝數代償增加,以及降低粒線體DNA突變量。在本研究中,人類素顯著增加了病患纖維母細胞內的ATP含量,同時有效維持細胞內的膜電位水平,增加粒線體呼吸鏈複合體 (respiratory complex) 相關蛋白之表達,並經由 Parkin-PINK1 訊息路徑加速粒線體自噬作用 (mitophagy) 清除損傷粒線體,進而維持細胞之能量功能。本研究結果確認粒線體衍生?人類素可以增強粒線體自噬作用清除損害粒線體的相關分子機制,並希望做為開發未來治療粒線體損傷相關疾病的方法。
    Mitophagy is one of the regulatory mechanisms of cell damage. Its function is to remove dysfunctional and redundant mitochondria, so as to control the number of mitochondria and the balance of energy metabolism. In skin fibroblasts that are mutated due to the loss of large mitochondrial fragments, the relevant mitochondrial clearance mechanism is particularly important. By clearing the mutant mitochondria, the expression of related genes in the body can be kept in balance without excessive. The compensatory effect or gene non-expression caused by the deletion, and previous studies have found that Humanin, one of the mitochondrial-derived peptides (MDP), acts as a signal for cellular protection and energy regulation in organisms, and can effectively regulate mitophagy, in order to speed up the removal of mutated mitochondria in the body, so that patients will not cause related diseases due to excessive accumulation of mutated mitochondria.
    Study mitochondria by culturing primary fibroblasts patient fibroblasts (PF)with mitochondrial mutations in vitro and comparing them with healthy controls (normal fibroblast, NF) or Immortalised cell line Detriol559 (Det) that observed the treatment of mitochondrial derived peptide-Humanin, the effect on mitochondrial mutants. Humanin and SHLPs regulate cell survival and growth via distinct pathways. Humanin can effectively mediate the retrograde message through intracellular and extracellular activation and protection pathways to deal with severe mitochondrial damage and cellular stress. And in our previous studies, we knew that humanin can effectively reduce the compensatory increase in mitochondrial DNA copy number and decrease the mutate road in patient fibroblasts.
    In this study, humanin increased the ATP level, and effectively maintained the membrane potential level in the patient's fibroblasts. Making the cells with normal mitochondrial function, less prone to apoptosis and accelerating damage to mitochondria body clearance, and increase the expression of mitochondria-related proteins to maintain the normal function of cells. The purpose of this study is to clarify the molecular mechanism of mitochondrial-derived peptides to clear damaged mitochondria, and hope to develop future treatments for mitochondrial damage diseases.
    描述: 碩士
    指導教授:高淑慧
    委員:高淑慧
    委員:郭雲鼎
    委員:張壯榮
    資料類型: thesis
    顯示於類別:[醫學檢驗暨生物技術學系所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML42檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋